Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

China · Delayed Price · Currency is CNY

50.78

-0.62 (-1.21%)

Feb 13, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Manufacturing	3.71B	3.15B	3.38B	3.00B	2.68B
Pharmaceutical Manufacturing Growth	17.69%	-6.85%	12.74%	12.02%	-39.17%
Medical Devices	305.41M	215.56M	100.44M	58.88M	60.95M
Medical Devices Growth	41.68%	114.63%	70.56%	-3.39%	-11.43%
Total	4.01B	3.37B	3.48B	3.06B	2.74B
Total Growth	19.22%	-3.35%	13.85%	11.68%	-38.74%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	4.01B	3.37B	3.48B	3.06B	2.74B
China Growth	19.22%	-3.35%	13.85%	11.68%	-38.74%
Total	4.01B	3.37B	3.48B	3.06B	2.74B
Total Growth	19.22%	-3.35%	13.85%	11.68%	-38.74%

Source: S&P Global Market Intelligence.